Biologics Reduce Symptoms of Alcohol Intolerance Better than Aspirin Desensitization in Patients with N-ERD and Nasal Polyps.
Ulrike Foerster-RuhrmannMiroslav JurkovAgnieszka J SzczepekKarl-Christian BergmannJoachim Wilhelm FluhrHeidi OlzePublished in: Biomedicines (2024)
This real-world study shows that alcohol-related respiratory symptoms are a relevant parameter in CRSwNP/N-ERD patients. Patients benefit more from biologic therapy than from ATAD in terms of their alcohol-related symptoms and other CRS symptoms. Future studies should include placebo-controlled oral alcohol challenge.
Keyphrases
- end stage renal disease
- chronic kidney disease
- peritoneal dialysis
- alcohol consumption
- rheumatoid arthritis
- clinical trial
- squamous cell carcinoma
- cardiovascular disease
- low dose
- randomized controlled trial
- radiation therapy
- stem cells
- coronary artery disease
- placebo controlled
- depressive symptoms
- study protocol
- physical activity
- cardiovascular events
- acute coronary syndrome
- current status
- cell therapy
- phase ii
- phase ii study